Please login to the form below
pharmcovigilance
This page shows the latest pharmcovigilance news and features for those working in and with pharma, biotech and healthcare.
Parexel adds flexibility to its clinical research offering
The localised services, which cover phase IIIb/IV trials, include site monitoring and site support activities, data management and programming, statistical analysis and pharmcovigilance.
Latest news
-
Tight squeeze
The pharma industry could face torrid times in 2007 as US Democrats mobilise plans to slash drug prices and take the industry to task on issues ranging from marketing to pharmcovigilance.
More from news
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
A new era of smart pharma
How smarter pharmaceuticals and pharmacovigilance are transforming healthcare
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Sanofi's frexalimab shows promise in relapsing forms of MS
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Amgen reports positive results for Otezla in psoriatic arthritis
- Supply chain challenges in 2023
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
Wiley
Wiley is a global leader in research and education. We’ve spent more than 200 years developing resources for college, career,...
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
